BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32902145)

  • 1. miR-5188 augments glioma growth, migration and invasion through an SP1-modulated FOXO1-PI3K/AKT-c-JUN-positive feedback circuit.
    Yi R; Yang S; Lin X; Zhong L; Liao Y; Hu Z; Huang T; Long H; Lin J; Wu Z; Xie C; Ding S; Luo J; Luo Q; Song Y
    J Cell Mol Med; 2020 Oct; 24(20):11800-11813. PubMed ID: 32902145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN.
    Zhao M; Luo R; Liu Y; Gao L; Fu Z; Fu Q; Luo X; Chen Y; Deng X; Liang Z; Li X; Cheng C; Liu Z; Fang W
    Nat Commun; 2016 Apr; 7():11309. PubMed ID: 27095304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
    Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
    Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
    Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timeless-Stimulated miR-5188-FOXO1/β-Catenin-c-Jun Feedback Loop Promotes Stemness via Ubiquitination of β-Catenin in Breast Cancer.
    Zou Y; Lin X; Bu J; Lin Z; Chen Y; Qiu Y; Mo H; Tang Y; Fang W; Wu Z
    Mol Ther; 2020 Jan; 28(1):313-327. PubMed ID: 31604679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of lncRNA-UCA1 inhibits cell viability and migration of human glioma cells by miR-193a-mediated downregulation of CDK6.
    Xin H; Liu N; Xu X; Zhang J; Li Y; Ma Y; Li G; Liang J
    J Cell Biochem; 2019 Sep; 120(9):15157-15169. PubMed ID: 31111564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells.
    Jin S; Li X; Dai Y; Li C; Wang D
    Cell Oncol (Dordr); 2020 Dec; 43(6):1035-1048. PubMed ID: 32986146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SP1 induced lncRNA CASC11 accelerates the glioma tumorigenesis through targeting FOXK1 via sponging miR-498.
    Jin J; Zhang S; Hu Y; Zhang Y; Guo C; Feng F
    Biomed Pharmacother; 2019 Aug; 116():108968. PubMed ID: 31121483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.
    Zhao M; Xu P; Liu Z; Zhen Y; Chen Y; Liu Y; Fu Q; Deng X; Liang Z; Li Y; Lin X; Fang W
    Cell Death Dis; 2018 Jan; 9(2):78. PubMed ID: 29362431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
    Lian R; Lu B; Jiao L; Li S; Wang H; Miao W; Yu W
    Eur J Pharmacol; 2016 Dec; 792():1-6. PubMed ID: 27751825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.
    Wang W; Jiang X; Xia F; Chen X; Li G; Liu L; Xu Q; Zhu M; Chen C
    Mol Biol Rep; 2023 Jan; 50(1):453-464. PubMed ID: 36348197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma.
    Bao L; Li X
    Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated microRNA-30b-3p inhibits proliferation, invasion and migration of glioma cells via inactivation of the AKT signaling pathway by up-regulating RECK.
    Jian Y; Xu CH; Li YP; Tang B; Xie SH; Zeng EM
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31270250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
    Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
    J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-135a inhibits glioma cell proliferation and invasion by directly targeting FOXO1.
    Shi HZ; Wang DN; Xu F; Teng JH; Wang YL
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4215-4223. PubMed ID: 30024610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-126 acts as a tumor suppressor in glioma cells by targeting insulin receptor substrate 1 (IRS-1).
    Luan Y; Zuo L; Zhang S; Wang G; Peng T
    Int J Clin Exp Pathol; 2015; 8(9):10345-54. PubMed ID: 26617742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.